Rockbridge Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Buy
2,002
+61
+3% +$7.14K 0.02% 130
2026
Q1
$234K Hold
1,941
– – 0.02% 133
2025
Q4
$204K Buy
+1,941
New +$182K 0.02% 134
2024
Q1
– Sell
-1,492
Closed -$163K – 434
2023
Q4
$163K Buy
+1,492
New +$155K 0.02% 136
2022
Q3
– Sell
-1,665
Closed -$152K – 408
2022
Q2
$152K Sell
1,665
-2,217
-57% -$197K 0.03% 119
2022
Q1
$324K Buy
3,882
+90
+2% +$7.1K 0.05% 116
2021
Q4
$291K Buy
3,792
+358
+10% +$28.5K 0.04% 140
2021
Q3
$258K Buy
3,434
+51
+2% +$3.88K 0.04% 124
2021
Q2
$263K Sell
3,383
-130
-4% -$9.67K 0.04% 127
2021
Q1
$258K Sell
3,513
-5,900
-63% -$435K 0.05% 120
2020
Q4
$735K Buy
9,413
+1
+0% +$76 0.15% 68
2020
Q3
$745K Buy
9,412
+1
+0% +$78 0.18% 59
2020
Q2
$694K Buy
+9,411
New +$708K 0.18% 62

Other funds holding MRK

Rockbridge Investment Management's MRK Position: Q2 2026 in Review

Rockbridge Investment Management increased its Merck (MRK) stake by 3.1% in Q2 2026, buying an estimated $7.14K and bringing the position to 2,002 shares worth $257K. The position accounts for 0.02% of the portfolio, ranked #130.

Rockbridge Investment Management first reported a position in MRK in Q2 2020 and has held it in 13 quarters since. The position peaked at $745K in Q3 2020. 3,850 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Rockbridge Investment Management held 2,002 shares of Merck worth $257K as of Q2 2026.
  • Rockbridge Investment Management bought 61 Merck shares in Q2 2026, an estimated $7.14K.
  • Merck made up 0.02% of Rockbridge Investment Management's portfolio in Q2 2026, its #130 holding.
  • Rockbridge Investment Management first reported a position in Merck in Q2 2020 and has held it in 13 quarters since.
  • Rockbridge Investment Management's Merck position peaked at $745K in Q3 2020.
  • 3,850 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Rockbridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.